|Previous Section||Index||Home Page|
Mr. Lansley: To ask the Secretary of State for Health with reference to the Answer of 23 October 2007, Official Report, column 272W, on NHS: Finance, how many NHSnet users there are; and what personally identifiable information is contained in the programme budgeting atlases. 
Mr. Bradshaw: The Programme Budget Atlases contain no direct personally identifiable information in the sense of names, identification numbers, postcodes etc. However, some of the statistics contained within the atlases are based on very small numbers of events and may, therefore, have the potential to identify an individual. There are now some 300,000 registered NHSnet users, over 132,000 of whom use the system on a daily basis.
Mr. Lansley: To ask the Secretary of State for Health (1) how much money will be transferred to primary care trusts from the Ministry of Justice in each financial year between 2008-09 and 2010-11 to fund the transfer of responsibility for healthcare escorts and bedwatches; 
This amount, uplifted for pay, prices, population changes and where applicable, local allowances, will be transferred from the Ministry of Justice to this Department for each year covered by the current comprehensive spending review settlement.
Primary care trusts will shortly receive a communication confirming their allocations for the provision of healthcare escort and bedwatches services for each prison establishment in England for this period. Allocations for 2008-09 will be based on local historical spend as identified in the audit. Allocations for 2009-10 and beyond will then be re-distributed based on a fair shares model agreed with Her Majestys Prison Service, which will take into account a number of factors including prison type, category and operational capacity.
(1) A Twelve Month Study of Prison Healthcare Escorts and Bedwatches, Department of Health, 2006.
Andrew Rosindell: To ask the Secretary of State for Health what the survival rate of those treated for prostate cancer in (a) Barking, Havering and Redbridge NHS Trust and (b) London NHS trusts is. 
The National Statistician has been asked to reply to your recent Parliamentary Question asking what the survival rate of those treated for prostate cancer in a) Barking, Havering and Redbridge NHS Trust and b) London NHS trusts is. I am replying in her absence. (167293)
Survival rates by NHS Trust are not available, but one and five-year survival for eight common cancers including prostate
cancer by government office region and strategic health authority, for patients diagnosed in 1997-99 and followed up to 31 December 2004, are available on the National Statistics website at:
Mr. Lansley: To ask the Secretary of State for Health (1) on what dates the Scientific Advisory Group on Pandemic Influenza met in 2007; and if he will place in the Library copies of the minutes of these meetings; 
(2) if he will place a copy in the Library of the empirical evidence referred to in section 2.4 of his Departments Pandemic Influenza Scientific Advisory Groups Subgroup on Modelling summary, dated November 2007, which demonstrates that local epidemics of pandemic influenza will vary in profile between primary care trust areas; 
(3) if he will consider the merits of a contingency strategy for an appropriate response in the event of an extreme pandemic as recommended in his Departments Pandemic Influenza Scientific Advisory Groups Subgroup on Modelling summary, dated November 2007. 
The empirical evidence referred to, from the Departments Pandemic Influenza Scientific Advisory Groups Subgroup on Modelling, concern 1918-19 influenza pandemic mortality data from England and Wales. The actual documents used by the Department are tables produced by Niall Johnson as part of his PhD project in the Department of Geography, University of Cambridge (1996-2001). The raw data in the Departments possession has been placed in the Library.
The modelling summary defines an extreme pandemic as one where the case fatality rate (CFR) is above the historic range, i.e. above 2.5 per cent. and indicates that
a policy question is how the response might change for such a pandemic. It does not recommend Government devises a contingency strategy for the situation. It recommends: Based on historical pandemics, a reasonable worst case for a pandemic would be a CFR of 2.5 per cent. This is the upper end of the CFR range considered in the contingency planning as described in the cross-Government national framework for responding to an influenza pandemic.
To ask the Secretary of State for Health how many (a) 15 to 19-year-olds and (b) adults over the age of 19-years-old in the Havering
Primary Care Trust area were (i) tested for and (ii) diagnosed with sexually transmitted infections in 2006. 
1. The data available from the KC60 statutory returns are for diagnoses made in GUM clinics only. Diagnoses made in other clinical settings, such as general practice, are not recorded in the KC60 dataset.
2. The data available from the KC60 statutory returns are the number of diagnoses made, not the number of patients diagnosed. Individual patients may have more than one diagnosis in a year.
3. The information provided has been adjusted for missing clinic data.
4. There is no reporting GUM clinic in the Havering PCT area.
5. Age groups are only available for chlamydia, gonorrhoea, primary and secondary syphilis, anogenital herpes and anogenital warts only.
6. STI testing data in GUM clinics is not collected by age group.
Health Protection Agency, KC60 returns
In addition to diagnoses made in GUM clinics, the national chlamydia screening programme (NCSP) has been running since 2003 in England. Information according to postcode of residence for those who have had a test and are positively diagnosed within the Havering PCT for 2006 is given in the following table.
|15 to 19||20 to 24|
1. The data from the NCSP are for diagnoses made outside of GUM clinics and include diagnoses made by the Boots pathfinder project in London.
2. The data available from the NCSP are the number of tests and diagnoses made and not the number of patients tested and diagnosed.
3. The NCSP screens those aged under 25 years.
4. Data as of 15 November 2007
National Chlamydia Screening Programme.
The National Statistician has been asked to reply to your recent Parliamentary Question asking Mr Chancellor of the Exchequer if he will collate figures for five-year survival rates for skin cancer on a regional basis. I am replying in her absence. (165504)
As noted in a response to a similar question you asked previously (Official Report volume 467, No. 10, column 921W, 21 November 2007) sub-national analyses of survival from specific cancers are only routinely undertaken for eight cancers, and do not include skin cancer. Further there are no plans to produce equivalent figures for other cancer sites. However, figures are available for skin cancer diagnosed during 1971-90 in England and Wales, broken down by region, and were provided in the earlier reply.
The sub-national analyses of survival for the eight cancers were produced in collaboration with the London School of Hygiene & Tropical Medicine (LSHTM). LSHTM were funded by National Centre for Health Outcomes Development (NCHOD)/Department of Health to produce analyses for these eight common cancers only. These figures were used by the National Heath Service as part of the Compendium of Clinical and Health Indicators.
Dawn Primarolo: The information is not available in the format requested. However, latest data on the percentage of adults aged 16 to 19 who smoke in Great Britain, broken down by gender are available from the 2005 General Household Survey and are shown in the following table.
Reducing the number of young people who smoke is a Government priority, which is why the minimum age of sale was raised to 18 from 1 October. Sanctions
against retailers who repeatedly flout the law on age of sale will also be introduced.
|Prevalence of cigarette smoking by sex and age, Great Britain, 1974 to 2005|
|Unweighted (percentage smoking cigarettes)|
|Persons aged 16 and over||1974||1978||1982||1986||1990||1994||1998|
|Next Section||Index||Home Page|